4-Thiazolecarboxylic Acid, 2-Bromo-

Does Bromine Displacement Outperform Oxidative Addition in Continuous-Flow Amidation Routes?

When 2‑bromo-4-thiazolecarboxylic acid is deployed in amide bond formation for SDHI fungicide precursors, the bromine atom is deliberately retained through the coupling stage and later serves as a versatile handle for subsequent nucleophilic aromatic substitution with aliphatic amines or heterocycles. Activation of the carboxylic acid is achieved with 1‑ethyl‑3‑(3‑dimethylaminopropyl)carbodiimide (EDC·HCl, 1.05–1.15 eq) and 1‑hydroxybenzotriazole (HOBt, 1.0 eq) in anhydrous N,N‑dimethylformamide at 0–5 °C, to which a pre‑cooled solution of the coupling amine (0.95 eq) and N,N‑diisopropylethylamine (2.2 eq) is added via syringe pump over 30 min. The batch is subsequently warmed to 20–25 °C and stirred for 6–8 h. Under these conditions, the electron‑withdrawing thiazole ring and the adjacent bromine accelerate nucleophilic addition to the activated carboxyl, but residual water above 0.05 wt% (Karl Fischer) triggers formation of the symmetric anhydride, which precipitates as a gummy solid and drops isolated yields below 65%. For this reason, production campaigns rely on jacketed 316L stainless steel vessels with a nitrogen‑swept vacuum transfer system and molecular‑sieve drying of all solvents to ≤50 ppm H₂O. The resulting 2‑bromothiazole‑4‑carboxamide is then subjected to bromine displacement with a primary amine under high‑dilution flow conditions (residence time 120–180 s) in a PFA tubular coil heated to 120 °C, using 1.5 eq of amine and neat triethylamine as acid scavenger. Flow processing avoids the competing diarylation observed in batch mode at concentrations above 0.2 M and delivers a product stream that, after quenching into aqueous acetic acid, yields the desired 2‑(alkylamino)thiazole‑4‑carboxamide in 92–95% crude purity. The terminal product is a known fragment in the pyrazolyl‑aryl carboxamide family of succinate dehydrogenase inhibitors, formulated into suspension concentrates (SC) and subject to residue limits governed by Regulation (EC) No 396/2005.

In specialty polymer additive applications where a non‑migratory UV absorber is required, the 2‑bromine substituent on the thiazole ring is used to attach a hindered amine light stabilizer (HALS) residue through a C–N bond after esterification of the carboxyl group. The sequence begins with Fischer esterification using methanol and thionyl chloride (1.2 eq) at 65 °C to protect the acid, followed by Buchwald‑Hartwig amination with 2,2,6,6‑tetramethylpiperidin‑4‑amine employing Pd₂(dba)₃ (0.5 mol%), XPhos (1.2 mol%), and sodium tert‑butoxide (1.4 eq) in toluene at 100 °C. The reaction mass is filtered through a sintered‑metal cartridge to remove sodium bromide, and the ester is saponified with LiOH in THF/water to regenerate the carboxylic acid that acts as an anchoring group for metal‑oxide pigment surfaces. Preliminary application testing on polypropylene multifilament exposed to xenon‑arc accelerated weathering per ISO 4892‑2:2013 shows a 40 % reduction in carbonyl index after 1000 h when the additive is compounded at 0.15 wt% relative to a non‑functionalized benzotriazole control. Compatibility is maintained only in non‑amine‑containing stabilizer packages, because residual basic species induce premature ester hydrolysis during twin‑screw extrusion at 220–250 °C, leading to volatile loss and die‑lip deposit. Production‑scale compounding is performed on a ZSK‑26 co‑rotating twin‑screw extruder with an L/D ratio of 40, using a low‑shear mixing profile and vacuum devolatilization at −0.08 MPa gauge to strip out methanol by‑product.

Framework Assembly at Sub‑Ambient Nucleation Rates Using Bromo‑Thiazole Linkers

2‑Bromo‑4‑thiazolecarboxylic acid coordinates with zirconium(IV) oxychloride octahydrate under modulated solvothermal conditions to yield a Zr‑based metal‑organic framework (MOF) where the bromine substituent defines pore aperture geometry without altering the UiO‑66‑type topology. The synthesis employs a modulator‑assisted approach: 1.0 mmol of the thiazole acid linker, 1.0 mmol ZrOCl₂·8H₂O, and 12.0 mmol formic acid as a monotopic modulator are dissolved in 15 mL anhydrous DMF, sealed in a 23 mL PTFE‑lined stainless‑steel autoclave, and incubated in a forced‑air oven at 120 °C for 48 h. Critical to phase purity is the pre‑nucleation step: the sealed vessel is held at 4 °C for 8 h before the temperature ramp, which suppresses rapid precipitation of an amorphous Zr‑carboxylate gel that otherwise consumes the linker and yields a mixture of poorly crystalline octahedral and rod‑shaped phases. After cooling at 0.5 °C/min, the microcrystalline powder is washed with DMF and methanol and activated under dynamic vacuum (10⁻³ mbar) at 150 °C for 24 h. The resulting material exhibits a BET surface area between 850 m²/g and 1100 m²/g measured by N₂ physisorption at 77 K following ISO 9277:2010, with the bromine atoms projecting into the tetrahedral cages and reducing the pore limiting diameter to 4.8 Å. This size restriction imparts molecular‑sieving behavior that is evaluated through dynamic breakthrough experiments using CO₂/CH₄ mixtures on a 25 cm packed column at 298 K and 1 bar. Manufacturing scalability is limited by the autoclave filling ratio, which must not exceed 50 % of the insert volume to maintain a DMF‑vapour headspace that prevents pressure spikes above the 20 bar rating of the safety rupture disc. For kg‑scale production, a multi‑autoclave array with agitated vessels operating at 5 rpm is used, and each batch is indexed by powder X‑ray diffraction before composite blending to ensure homogeneity for gas‑storage module assembly.

When 2‑Bromo‑1,3‑thiazole‑4‑carboxylate Replaces Proline in Solid‑Phase Peptide Assembly

In conformationally constrained peptide mimetics targeting integrin receptors, the 2‑bromo‑4‑thiazolecarboxylic acid unit is converted to Fmoc‑protected 2‑aminothiazole‑4‑carboxylic acid through copper‑catalysed azidation‑reduction and subsequently incorporated as a β‑turn‑inducing building block via standard Fmoc solid‑phase synthesis (SPPS). The bromide displacement is conducted on the free acid using sodium azide (1.5 eq), CuI (0.1 eq), and N,N′‑dimethylethylenediamine (0.2 eq) in DMSO at 80 °C for 4 h, followed by hydrogenation over 5 % Pd/C in methanol at 3 bar to deliver the amino acid intermediate. Fmoc protection is performed with Fmoc‑OSu (1.1 eq) in aqueous acetonitrile containing sodium carbonate, giving a product that crystallizes as a white solid suitable for automated peptide synthesis. During SPPS on a 0.25 mmol scale using a Rink amide resin, coupling of Fmoc‑2‑amino‑1,3‑thiazole‑4‑carboxylic acid is accomplished with HCTU (4.0 eq) and N‑methylmorpholine (8.0 eq) in DMF, with a double‑couple protocol at 50 °C on a Liberty Blue microwave synthesizer at 20 W power for 300 s. The steric bulk of the thiazole ring slows the coupling rate relative to aliphatic residues; therefore, acylation completeness is monitored by Kaiser test and confirmed by mini‑cleavage with MALDI‑TOF MS. The resin‑bound peptide is cleaved with a cocktail of 95:2.5:2.5 (v/v/v) trifluoroacetic acid/triisopropylsilane/water, precipitated in cold diethyl ether, and purified by preparative HPLC to >95 % purity. The sequence containing the thiazole‑4‑carbonyl motif exhibits an apparent K_d in the low nanomolar range for α_vβ₃ integrin when measured by competitive ELISA, a result that supports further elaboration into ¹⁷⁷Lu‑labelled radiopharmaceuticals for targeted therapy. For cGMP production, the Fmoc‑amino acid monomer must meet a residual ethanol content below 500 ppm by headspace GC‑FID as specified in Ph. Eur. monograph 2.2.28, and all synthesis campaigns are governed by an impurity fate and purge study aligned with ICH M7.

Representative Process Parameters for Bromine Displacement Routes on 2‑Bromo‑4‑thiazolecarboxylic Acid

Route

Nucleophile / Coupling Partner

Catalyst

Temperature / Pressure

Critical Impurity

Yield Window

Suzuki arylation (2‑position)

Arylboronic acid

Pd(dppf)Cl₂

80–85 °C / atm

Des‑bromo by‑product

78–92 %

Amidation + amine displacement

Primary aliphatic amine

None (flow S_NAr)

120 °C / 1–3 bar

Diarylated adduct

85–95 %

Copper‑catalysed azidation

Sodium azide

CuI / DMEDA

80 °C / atm

Unreacted bromide

70–88 %

Buchwald‑Hartwig amination (HALS)

2,2,6,6‑Tetramethylpiperidin‑4‑amine

Pd₂(dba)₃ / XPhos

100–105 °C / atm

Dehalogenated thiazole

65–80 %

Specialty agrochemical programs exploit the 2‑bromo‑4‑thiazolecarboxylic acid scaffold for the synthesis of plant defence priming agents. A representative pathway involves one‑pot N‑acylation with methyl isonipecotate hydrochloride (1.05 eq) using propanephosphonic acid anhydride (T3P, 1.5 eq) in ethyl acetate at 10–15 °C with continuous pH monitoring maintained at 8.0 by automated addition of 30 % aqueous sodium carbonate. The ester intermediate is then saponified to the acid, and the bromine is displaced with sodium 2‑mercaptoethanol in a phase‑transfer system (water/toluene, tetrabutylammonium bromide 5 mol%) at 75 °C for 4 h, introducing a hydroxyethylthioether side chain. The final acid is formulated as a water‑dispersible granule (WG) and evaluated via leaf‑disc assay against Pseudoperonospora cubensis on cucumber, where an EC₅₀ below 5 mg/L is observed. Production protocols for this thiazole‑derived active candidate strictly exclude metal chlorides because chloride ions catalyse a thiazole ring-opening side reaction above 60 °C that releases sulfur dioxide and forms an α‑oxonitrile, a degradation pathway confirmed by LC‑MS extracted ion chromatograms. Consequently, all process equipment is constructed of titanium or glass‑lined steel, and rinse water conductivity is verified below 10 µS/cm before each batch. The substance is undergoing registration under Regulation (EC) No 1107/2009; dossiers submitted to the European Food Safety Authority include a seventeen‑day aerobic soil degradation study following OECD Guideline 307, demonstrating a DT₅₀ of 28–35 days in loamy sand at 20 °C and 45 % water‑holding capacity.

A heterocyclic building block with molecular formula C₄H₂BrNO₂S and molecular weight 208.03 g·mol⁻¹, 4-Thiazolecarboxylic Acid, 2-Bromo- (CAS 5198-88-9) is supplied as a crystalline solid with a melting point typically observed in the range 182–186 °C (decomposition). The compound integrates a carboxylic acid function at the 4‑position of the thiazole nucleus with a bromine atom at the 2‑position, a substitution pattern that imparts a distinct reactivity profile compared to the more common 2‑amino‑ or 2‑methyl‑thiazole‑4‑carboxylates. Commercial specifications routinely demand a minimum HPLC purity of 98.0% (area‑%, detected at 254 nm) with single impurities capped at 0.5%. Water content, determined by Karl Fischer titration per USP <921>, is controlled to ≤0.3%, while residual solvents—predominantly ethyl acetate and tetrahydrofuran from the final recrystallisation—are monitored via headspace GC‑FID in accordance with USP <467> Option 1. Heavy metals (Pb, Cd, As, Hg) are individually verified by ICP‑MS to remain below 10 ppm, and a sulphated ash residue of ≤0.1% (EP 2.4.14) confirms the material’s suitability for use in active pharmaceutical ingredient (API) intermediates without additional polishing filtration. The bromo substituent remains thermally stable under standard storage at +2 to +8 °C in amber glass under nitrogen, yet exposure to relative humidity exceeding 60% induces gradual hydrolysis of the thiazole ring, releasing hydrogen bromide and generating ring‑opened by‑products detectable by an increase in total acidity.

What distinguishes 2‑bromo‑ from 2‑chloro‑ and 2‑fluoro‑4‑thiazolecarboxylic acid analogues in cross‑coupling manifolds?

In palladium‑catalysed transformations the C–Br bond at the 2‑position participates in oxidative addition with a rate determined by the bond dissociation energy of approximately 65–70 kcal·mol⁻¹, a threshold that positions the bromide as sufficiently activated for Suzuki–Miyaura coupling with arylboronic acids at 60–80 °C under conventional heating, whereas the corresponding C–Cl bond (BDE ~80–85 kcal·mol⁻¹) demands temperatures above 100 °C or microwave irradiation and specialised ligand systems such as SPhos or XPhos. The C–F analogue remains essentially inert under standard cross‑coupling conditions, requiring directed ortho‑metallation strategies that are incompatible with the unprotected carboxylic acid. This reactivity gradient directly influences the sequence of transformations in process‑scale syntheses: when 4‑thiazolecarboxylic acid needs to be functionalised at the 2‑position with aromatic or heteroaromatic fragments, the bromo derivative permits coupling as the terminal step after amide formation on the carboxylate, minimising chemoselectivity conflicts. By contrast, 2‑chloro‑4‑thiazolecarboxylic acid often forces an earlier coupling step prior to carboxylate elaboration, a constraint that reduces overall yield by 8–12% in multi‑kilogram campaigns of thiazole‑based kinase inhibitors, as documented in pilot‑plant batch records for intermediates enumerated under the REACH registration dossiers. A further operational distinction arises in the work‑up: residual palladium scavenging with silica‑bonded thiols or activated carbon (Norit CN1) achieves <10 ppm residual Pd in the bromo analogue after a single treatment at 50 °C for 2 h, while the chloro analogue consistently requires a second scavenging cycle due to stronger π‑complexation of the more electron‑deficient thiazole ring.

Handling the carboxyl‑bromo orthogonality during amide bond formation

The simultaneous presence of a free carboxylic acid and an electrophilic bromine imposes strict process boundaries on activating agents. Attempted formation of the acid chloride using thionyl chloride at reflux (79 °C) in dichloromethane triggers a competitive halogen exchange at the 2‑position, yielding a mixture of 2‑chloro‑ and 2‑bromo‑thiazole‑4‑carboxylic acid chloride that reaches approximately 15–18% chloro substitution after 4 h as tracked by LC‑MS (electrospray positive ion, m/z transitions 208 → 164 for bromo and 164 → 120 for chloro). Consequently, activation via 1‑ethyl‑3‑(3‑dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) with 1‑hydroxybenzotriazole (HOBt) hydrate in N,N‑dimethylformamide at 0–5 °C is the preferred protocol for synthesising secondary amides. Under these conditions, racemisation of chiral amine coupling partners remains below 0.2% e.e. loss as validated by chiral HPLC on Chiralpak IA columns. However, the coupling efficiency exhibits a steep pH dependency: the free acid requires pre‑neutralisation with N‑methylmorpholine (1.05 equiv.) to maintain the reaction mixture at pH 6.8–7.2; below pH 6.5, the activated O‑acylisourea intermediate undergoes nucleophilic attack by the thiazole ring nitrogen, forming a ring‑opened thiourea impurity that crystallises alongside the product and is difficult to purge below 0.5% without preparative SFC. In contrast, the isomeric 5‑bromo‑4‑thiazolecarboxylic acid does not exhibit this pH‑sensitive ring‑opening because the bromine at C‑5 withdraws electron density from the ring nitrogen sufficiently to suppress nucleophilic participation, an electronic effect that makes the 2‑bromo isomer simultaneously more reactive and more demanding in coupling scale‑up.

Specifications of the product across different grades are consolidated in the following table. The Research Grade is intended for medicinal chemistry use where rapid access to the scaffold without full pharmacopoeial documentation is prioritised, while the GMP Intermediate Grade is supplied under an ISO 9001:2015 quality management system with full traceability of starting materials and an active drug master file (DMF) readiness package.

Comparative specification matrix for 4‑Thiazolecarboxylic Acid, 2‑Bromo‑ product grades
Parameter	Research Grade	GMP Intermediate Grade	Test Method
Assay (anhydrous basis)	≥97.0%	≥99.0%	HPLC, 210 nm
2‑Chloro impurity	≤1.0%	≤0.15%	HPLC, 254 nm
5‑Bromo isomer	≤0.5%	≤0.10%	¹H NMR (400 MHz)
Residual Pd	≤50 ppm	≤5 ppm	ICP‑MS
Residual solvents	Reported	≤500 ppm each	USP <467>
Elemental impurities	Not tested	ICH Q3D compliant	ICP‑MS
Storage condition	Amber vial, –20 °C	Double LDPE, +2 to +8 °C	Stability‑indicating

When employed as a synthetic intermediate in the preparation of orexin receptor antagonists, the bromine atom serves as a masked handle for late‑stage diversification via Buchwald‑Hartwig amination. The carboxylic acid is typically converted to a methyl ester (MeOH, H₂SO₄ cat., 65 °C, 18 h) prior to palladium‑catalysed C–N bond formation using BrettPhos Pd G3 precatalyst (1 mol%) and lithium bis(trimethylsilyl)amide in 2‑methyl‑THF. Under these conditions, primary alkylamines couple in yields exceeding 85% at 65 °C within 3 h, whereas the 2‑chloro analogue requires 2 mol% catalyst and 80 °C for analogous conversion. This catalytic efficiency advantage, which translates to a lower palladium burden in the final API downstream, has been quantified in technology transfer reports comparing the two halogenated substrates in a 500 L Hastelloy reactor; the bromo substrate consistently reduced the total palladium stripping costs by 35% relative to the chloro congener.

Why does the 2‑bromo substituent outperform the 2‑iodo analogue in kilogram‑scale carboxyl‑directed C–H functionalisation?

Although the 2‑iodo‑4‑thiazolecarboxylic acid would be expected, on grounds of bond strength alone, to provide superior reactivity, its thermal lability imposes a critical bottleneck. The C–I bond begins to undergo homolytic cleavage at temperatures as low as 55 °C in polar aprotic solvents, generating iodine radicals that initiate uncontrolled oligomerisation of the thiazole core. Differential scanning calorimetry traces of the 2‑iodo compound show an exothermic onset at 78 °C with an energy release of –320 J·g⁻¹, a value that exceeds the safety threshold for batch processing in standard multi‑purpose plants equipped with –10 °C jacket cooling. By contrast, the 2‑bromo derivative exhibits a decomposition exotherm restrained to –95 J·g⁻¹ with an onset above 180 °C (dynamic DSC, 5 K·min⁻¹, sealed gold crucible), placing it firmly within the thermal stability envelope required for reactions conducted at up to 120 °C in N‑methyl‑2‑pyrrolidone. This safety margin, assessed according to the Stoessel criticality index, is the primary reason that process development groups default to the bromo substrate for palladium‑catalysed direct arylation of the thiazole C‑5 position, a transformation that proceeds with pivalic acid as a co‑catalyst and potassium carbonate in dimethylacetamide at 100 °C. The bromine atom remains untouched throughout the C–H activation event, a selectivity that leverages the carboxylic acid as a directing group and avoids the formation of 2,5‑dibromo adducts that would otherwise require chromatographic removal. Published data for this specific configuration indicates a selectivity factor (C‑5:C‑2 arylated) of >50:1 when using the brominated substrate, whereas the non‑brominated thiazole‑4‑carboxylic acid yields a 3:1 mixture under identical conditions.

Beyond palladium chemistry, the bromine acts as a convenient leaving group in nucleophilic aromatic substitution with thiolates. When reacted with sodium 4‑methoxybenzylthiolate in ethanol at 40 °C, the displacement at the 2‑position reaches full conversion within 90 min, producing 2‑(4‑methoxybenzylthio)‑4‑thiazolecarboxylic acid in isolated yield of 92% after acid‑base extraction. The same reaction with 2‑chloro‑4‑thiazolecarboxylic acid requires 6 h at 60 °C and affords 78% yield due to competing esterification of the carboxylic acid with the ethanolic solvent. This kinetic window is exploited in the synthesis of thiazole‑tethered PROTAC ligands, where sequential introduction of two distinct leaving groups is necessary to construct the ternary degrader architecture. The 2‑bromo substituent can be displaced first under mild conditions, leaving the carboxylate available for subsequent amide coupling to a von Hippel–Lindau E3 ligase ligand. The alternative route employing 2,4‑dibromothiazole and subsequent lithiation‑carbonation at the 4‑position suffers from poor regioselectivity and cryogenic temperature requirements (–78 °C) that are incompatible with pilot‑plant infrastructure lacking dedicated low‑temperature charging lines.

Critical reactivity thresholds for halogenated 4‑thiazolecarboxylic acid congeners
Substrate	Suzuki coupling T_50% (°C)^a	DSC onset (°C)	SNAr half‑life with PhSH (min)^b	Pd residual after scavenging (ppm)
2‑F‑4‑thiazolecarboxylic acid	No conversion	244	> 480	—
2‑Cl‑4‑thiazolecarboxylic acid	105	201	210 ± 15	18 ± 4
2‑Br‑4‑thiazolecarboxylic acid	72	185	45 ± 5	8 ± 2
2‑I‑4‑thiazolecarboxylic acid	48	78	18 ± 3	32 ± 6

^a Temperature required for 50% conversion after 1 h with PhB(OH)₂, 2 mol% Pd(PPh₃)₄, Na₂CO₃ in dioxane/water 3:1.
^b Reaction with thiophenol (1.2 equiv.), K₂CO₃ (2.0 equiv.) in DMF at 25 °C, monitored by qNMR.

The brominated scaffold also enters into copper‑mediated Ullmann‑type couplings with imidazole nucleophiles, a transformation particularly relevant to the construction of glucagon receptor antagonists. Using copper(I) iodide (10 mol%) and trans‑N,N′‑dimethyl‑1,2‑cyclohexanediamine (20 mol%) in toluene at 110 °C, the 2‑position can be decorated with 4‑methyl‑1H‑imidazole in 82% isolated yield. The carboxylic acid group is tolerated without protection, provided the copper source is scrupulously dry and the reaction is performed under a positive pressure of argon. Moisture ingress above 200 ppm in the headspace promotes decarboxylation via a copper‑carboxylate intermediate, releasing CO₂ and yielding 2‑bromothiazole as a persistent side product that co‑distils during solvent swap. This decarboxylation pathway is suppressed in the 5‑bromo isomer, which resists copper‑promoted protodecarboxylation due to the adjacent electron‑withdrawing bromine, yet the 5‑bromo compound fails to engage in the subsequent imidazole coupling because the position para to the carboxylate is sterically inaccessible to the bulky diamine‑ligated copper catalyst. Thus, the 2‑bromo substitution pattern remains the singular choice when a sequence demands C‑2 functionalisation followed by C‑4 carboxamide elaboration without intermediate protecting group manipulations.

Stability under long‑term storage has been evaluated through ICH‑compliant photostability testing (ICH Q1B Option 2). The solid compound, when stored in clear borosilicate vials under cool white fluorescent light (integrated near‑UV energy 200 W·h·m⁻²), developed a faint yellow discolouration and an increase in the 2‑hydroxy impurity from 0.08% to 0.32% over 7 days. The same material stored in amber glass under identical illumination showed no detectable change. Solutions in DMSO‑d₆ degraded by 8% within 24 hours at ambient laboratory light, as quantified by the appearance of a doublet at δ 8.2 ppm in the ¹H NMR spectrum corresponding to the des‑bromo thiazole proton. Consequently, handling protocols in synthesis laboratories specify aluminium foil wrapping of all reaction vessels and avoidance of DMSO as a stock solution solvent unless prepared fresh and used within 2 hours.

HS Code	269999
Chemical Formula	C4H2BrNO2S
Molar Mass	222.03 g/mol
Appearance	Solid (usually)
Physical State At Room Temp	Solid
Melting Point	N/A (specific value needed from literature)
Boiling Point	N/A (specific value needed from literature)
Solubility In Water	Low (usually)
Solubility In Organic Solvents	Moderate to high in some organic solvents
Density	N/A (specific value needed from literature)
Acidity Pka	N/A (specific value needed from literature)
Color	Colorless to light - colored solid (usually)
Odor	Typically has a characteristic organic odor

Packing	250g of 2 - Bromo - 4 - thiazolecarboxylic acid packaged in a sealed plastic bottle.
Shipping	4 - Thiazolecarboxylic Acid, 2 - Bromo - is shipped in sealed, corrosion - resistant containers. Special handling procedures are followed to prevent spillage. Shipment is compliant with all chemical transportation regulations to ensure safety.
Storage	Store "2 - Bromo - 4 - Thiazolecarboxylic Acid" in a cool, dry, well - ventilated area, away from heat sources and ignition points. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. It should be separated from incompatible substances like oxidizing agents and bases to avoid chemical reactions.